How resurrecting extinct species might impact medicine

Off addiction, Biotech, biotechnology, Business, drug development, drug prices, drug pricing, finance, genetics, Health, Human Health, Life Sciences, Medicine, Pharma, Pharmaceuticals, policy, Politics, rare diseases, research, Science and Research, The Readout

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

Hey, it’s Meghana. Today, we see how the GLP-1s might be harnessed for Parkinson’s, we learn about species de-extinction efforts, and BIO’s CEO tells us why the U.S. needs to stay on top in biotech.

Read the rest…

Read Original Article: How resurrecting extinct species might impact medicine »

About The Author